John D Blakey

John D Blakey serves as a Clinical Senior Lecturer within the Internal Medicine department at the UWA Medical School, University of Western Australia. As a Respiratory Physician specializing in airways diseases, his clinical and research work centers on asthma and chronic obstructive pulmonary disease (COPD). His contributions align with UN Sustainable Development Goals related to good health and well-being, reflecting a commitment to improving respiratory healthcare outcomes through evidence-based practice and innovation.

Dr. Blakey's research program emphasizes the clinical management of asthma, particularly the implementation of newer information technologies to enhance patient care. His expertise extends to primary health care delivery, respiratory disease epidemiology, and the role of biomarkers in severe asthma. Recent work addresses critical gaps in understanding the environmental impact of inhaled medications and the application of predictive analytics for hospital-acquired complications, demonstrating an interdisciplinary approach that bridges respiratory medicine with health informatics.

Analysis of his 2025 publications reveals a cohesive research trajectory focused on optimizing asthma care through personalized treatment strategies. Key themes include biomarker-driven management of severe asthma, sustainability in respiratory pharmacotherapy, and health system factors influencing evidence-based care. His collaborative work with the Thoracic Society of Australia and New Zealand highlights policy-relevant research, while AI-driven studies indicate growing interest in digital health solutions for complex clinical challenges.

Although no specific scientific awards are documented in the available materials, Dr. Blakey maintains an active research profile with significant scholarly impact.

As principal investigator on ten major grants (five active and five completed), Dr. Blakey leads projects addressing critical respiratory health challenges. Current initiatives include community-based asthma diagnostic services (Chiesi Australia), novel biologic therapies for asthma (Syneos Health), corticosteroid minimization strategies (Medical Research Future Fund), and cough treatment innovations (IQVIA RDS). These projects demonstrate his leadership in translating research into clinical practice across multiple healthcare settings.